4/A//SEC Filing
Gross Jeffrey M 4/A
Accession 0001096481-11-000019
CIK 0001096481other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 6:38 PM ET
Size
22.3 KB
Accession
0001096481-11-000019
Insider Transaction Report
Form 4/AAmended
Gross Jeffrey M
SVP, Research & Development
Transactions
- Other
Stock Option w/Tandem SAR
2011-05-12−85,000→ 275,000 totalExercise: $1.09From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying) - Other
Common Stock
2011-05-12−9,000→ 42,000 total - Other
Common Stock
2011-05-12−6,000→ 36,000 total - Other
Common Stock
2011-05-12−2,000→ 32,500 total - Other
Common Stock
2011-05-12−1,500→ 34,500 total - Other
Common Stock
2011-05-12−20,000→ 12,500 total - Other
Stock Option w/Tandem SAR
2011-05-12−100,000→ 25,000 totalExercise: $0.21From: 2009-01-01Exp: 2013-12-07→ Common Stock (100,000 underlying) - Other
Stock Option w/Tandem SAR
2011-05-12−25,000→ 0 totalExercise: $7.61From: 2007-08-01Exp: 2012-07-02→ Common Stock (25,000 underlying) - Other
Common Stock
2011-05-12−12,500→ 0 total - Other
Stock Option w/Tandem SAR
2011-05-12−150,000→ 125,000 totalExercise: $0.38From: 2009-04-01Exp: 2014-03-09→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).
- [F2]Price in in Canadian $.
Documents
Issuer
ANGIOTECH PHARMACEUTICALS INC
CIK 0001096481
Entity typeother
Related Parties
1- filerCIK 0001448731
Filing Metadata
- Form type
- 4/A
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 6:38 PM ET
- Size
- 22.3 KB